Company filings profile · CIK 0000793171
Vitro Biopharma, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Vitro Biopharma, Inc.: 2 filings in the last 90 days vs 1 in the prior 90 (filing-velocity rising ↑ · 2×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Sep 19, 2026. Source-linked, daily-refreshed.
Material 8-K events — Vitro Biopharma, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Jul 22, 2024 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jun 27, 2024 | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| May 17, 2024 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Apr 17, 2024 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jan 23, 2024 | Departure/Election of Directors or Officers; Other Events; Financial Statements and Exhibits | ↗ |
| Jan 16, 2024 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
Watch Vitro Biopharma, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
| Filed | Form | |
|---|---|---|
| No insider filings in the current window. | ||
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Sep 18, 2026 | 10-Q | 10-Q | ↗ |
| Sep 14, 2026 | NT 10-Q | NT 10-Q | ↗ |
| Jun 15, 2026 | 10-Q | 10-Q | ↗ |
| Mar 16, 2026 | 10-Q | 10-Q | ↗ |
| Feb 13, 2026 | 10-K | 10-K | ↗ |
| Jan 29, 2026 | NT 10-K | NT 10-K | ↗ |
| Sep 12, 2025 | 10-Q | 10-Q | ↗ |
| Jun 20, 2025 | 10-Q | 10-Q | ↗ |
| Jun 16, 2025 | NT 10-Q | NT 10-Q | ↗ |
| Jun 11, 2025 | D | Item 06b | ↗ |
| Mar 20, 2025 | 10-Q | ↗ | |
| Mar 17, 2025 | NT 10-Q | ↗ | |
| Jan 28, 2025 | 10-K | ↗ | |
| Sep 16, 2024 | 10-Q | ↗ | |
| Sep 11, 2024 | EFFECT | Item S-1; Item ; Item 2024-09-11 16:30:00 | ↗ |
| Sep 10, 2024 | CORRESP | ↗ | |
| Sep 10, 2024 | CORRESP | ↗ | |
| Sep 5, 2024 | S-1/A | ↗ | |
| Aug 29, 2024 | CORRESP | ↗ | |
| Aug 29, 2024 | UPLOAD | ↗ | |
| Aug 23, 2024 | CORRESP | ↗ | |
| Aug 23, 2024 | S-1/A | ↗ | |
| Aug 20, 2024 | UPLOAD | ↗ | |
| Aug 8, 2024 | CORRESP | ↗ | |
| Aug 8, 2024 | S-1/A | ↗ | |
| Jul 26, 2024 | UPLOAD | ↗ | |
| Jul 22, 2024 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jul 1, 2024 | CORRESP | ↗ | |
| Jul 1, 2024 | S-1/A | ↗ | |
| Jun 27, 2024 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| May 31, 2024 | 10-Q | ↗ | |
| May 17, 2024 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Apr 17, 2024 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Mar 14, 2024 | 10-Q | ↗ | |
| Feb 21, 2024 | UPLOAD | ↗ | |
| Feb 2, 2024 | CORRESP | ↗ | |
| Feb 2, 2024 | S-1/A | ↗ | |
| Jan 29, 2024 | 10-K | ↗ | |
| Jan 23, 2024 | 8-K | Departure/Election of Directors or Officers; Other Events; Financial Statements and Exhibits | ↗ |
| Jan 16, 2024 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |